2020 annual financial data
C4 Therapeutics, Inc. 2020 Operating margin
C4 Therapeutics, Inc. 2020 operating margin with verified reported values.
Direct answer
Operating margin was -182.1%.
Operating income was -60,449,000 USD and net income was -66,334,999 USD.
Operating cash flow was -67,249,000 USD.
Get free C4 Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 33,195,000 USD
- Operating income
- -60,449,000 USD
- Net income
- -66,334,999 USD
- Operating cash flow
- -67,249,000 USD